Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Suven Life Sciences Gains 6%; BSE HEALTHCARE Index Down 0.7%
Wed, 23 Oct 9:19

Suven Life Sciences Gains 6%; BSE HEALTHCARE Index Down 0.7%Image source: DNY59/www.istockphoto.com

Suven Life Sciences share price has zoomed 6% and is presently trading at Rs 121.5.

Meanwhile, the BSE HEALTHCARE index is at 42,783.0 (down 0.7%).

Among the top gainers in the BSE HEALTHCARE index today are ASTRAZENECA PHARMA (up 3.6%) and GSK Pharma (up 1.9%).

IPCA Labs (down 6.0%) and ERIS LIFESCIENCES (down 2.9%) are among the top losers today.

Over the last one year, Suven Life Sciences has moved up from Rs 65.5 to Rs 121.5, registering a gain of Rs 56.0 (up 85.5%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,503.7 to 42,783.0, registering a gain of 55.6% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 214.3%), Glenmark Pharma (up 120.3%) and SUVEN PHARMACEUTICALS (up 117.9%).

Don't Miss: Key Information for Long-term Investors

What About the Benchmark Indices?

The BSE Sensex is at 79,921.1 (down 0.4%).

The top losers among the BSE Sensex today are JSW Steel (down 1.4%) and Power Grid Corp. (down 1.3%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,378.2 (down 0.4%). Hindustan Unilever and Shriram Transport are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 64,571.9 to 79,921.1, registering a gain of 15,349.3 points (up 23.8%).

Suven Life Sciences Financial Update...

Suven Life Sciences net profit fell 16.4% YoY to Rs -280 million for the quarter ended June 2024, compared to a loss of Rs 241 million a year ago. Net sales declined 73.5% to Rs 10 million during the period as against Rs 38 million in April-June 2023.

For the year ended March 2024, Suven Life Sciences reported 11.2% increase in net profit to Rs -1,051 million compared to net loss of Rs 1,183 million during FY23. Revenue of the company fell 13.6% to Rs 117 million during FY24.

The current Price to earnings ratio of Suven Life Sciences, based on rolling 12 month earnings, stands at -24.3.


Equitymaster requests your view! Post a comment on "Suven Life Sciences Gains 6%; BSE HEALTHCARE Index Down 0.7%". Click here!